A user's guide to over-the-counter drugs

Elswick, Jill
November 2003
Employee Benefit News;Nov2003, Vol. 17 Issue 14, p52
Provides information on the nature and accessibility of over-the-counter drugs in the U.S. Prevalence of medications that can be bought without prescriptions; Factors to remember when buying over-the-counter drugs; Advice from experts when deciding to try over-the-counter drugs.


Related Articles

  • Patient Information Leaflet.  // Royal Society of Medicine: Medicines;2002, p428 

    This article defines Patient Information Leaflet, or Product Information Leaflet. It is the technical literature placed by the drug manufacturer in the packaging of medicines, and is intended to be read by the patient or carer. In the case of over-the-counter drugs, medicines that can be bought...

  • Do expiration dates make a difference? Gebhart, Fred // Drug Topics;10/10/2005, Vol. 149 Issue 19, p50 

    This article focuses on the importance of monitoring expiration dates of drugs. A Harris poll conducted in June 2005 found that 61 percent of Americans regularly check expiration dates on over-the-counter (OTC) medications, but a new survey indicates that nearly half of American adults have used...

  • OTC growth for Europe set at 16 percent. Wentz, Laurel // Advertising Age;4/27/1992, Vol. 63 Issue 17, pI-32 

    The article highlights a study which predicts that Europe's over-the-counter (OTC) healthcare market will grow 16 percent between 1990-1995 as pharmaceutical products increasingly switch from prescription to OTC status. The study predicts that the highest growth rates for the five-year period...

  • Increasing consumerization drives OTC growth in Europe.  // European Pharmaceutical Executive;May2007, p14 

    The article focuses on the growth of the over-the-counter (OTC) drug market in Europe. The continuing awakening in consumer healthcare consciousness will drive the market to grow at around three percent over the next five years from 2007. This outlook continues the upward trend in the top five...

  • Interest grows in probiotics, while antacids provide sales clout. Scalise, Annette // Drug Store News;1/15/2001, Vol. 23 Issue 1, p33 

    Discusses the opportunities presented by probiotic dietary supplements to pharmaceutical companies. Expectations on over-the-counter preparation; Role of health care professionals; Products of several manufacturers.

  • IMS INSIGHTS GLOBAL OTC MARKET.  // Medical Marketing & Media;Aug2005, Vol. 40 Issue 8, p8 

    Presents statistics on the performance of the global over-the-counter (OTC) market. Percentage increase in OTC sales in 2004; Top OTC growth contributors for 2004; Market share of OTC drugs in the overall pharmaceutical industry.

  • The Future of Rx-to-OTC Switches. Stibel, Gary; Kapoor, Gaurav // Pharmaceutical Executive;Dec2002, Vol. 22 Issue 12, p98 

    Reports on the development of over-the-counter products in the U.S. Creation of successful brand extensions; Collaboration between the Rx and over the counter pharmaceutical companies; Management of narrow products to holistic brand franchise.

  • Newsbites.  // Drug Store News;7/22/96, Vol. 18 Issue 11, p19 

    Reports on developments concerning over-the-counter drug manufacturers in the United States as of July 22, 1996. Federal Trade Commission's accusations against Ciba Self-Medication Inc. and its parent Ciba-Geigy Corp., of making false and misleading statements about Doan's pills for back pain;...

  • Newsbites.  // Drug Store News;3/3/97, Vol. 19 Issue 5, p21 

    Reports on over-the-counter (OTC) drug-related news from the United States, compiled as of March 3, 1997. Includes news on the Food and Drug Administration's approval of Bristol-Myers Squibb's plan to switch its Vagistat-1 one-day yeast infection treatment from prescription to OTC status;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics